Evaluation of the usefulness of a device for Human Papilloma Virus DNA collection and reservation in self-collected cervicovaginal samples stored dry in women with cervical dysplasia, Bogotá, Colombia

Authors

  • Luis Jairo Bonilla-Osma
  • Jairo Amaya-Guio
  • Patricia Olaya-García
  • Luis Bonilla-Bula

DOI:

https://doi.org/10.18597/rcog.3149

Keywords:

Human papilloma virus DNA testing, vaginal smear, self-testing, specimen handling

Abstract

Objective: To evaluate the usefulness of a device for collecting and preserving human papilloma virus (HPV) DNA in self-collected vaginal samples stored dry during 14 days.

Materials  and methods: Diagnostic concordance pilot study that included non-pregnant women over 24 years of age with a  biopsy-confirmed result of cervical intraepithelial neoplasia (CIN)  grade 1 or more, coming to two referral centres in Bogotá, Colombia. Women with a history of total hysterectomy were excluded. Convenience sampling was used. The device uses real-time PCR (polymerase chain reaction) for DNA detection. Sociodemographic and clinical variables were measured, as well as the results of the test when the sample was collected by the patient and when it was collected by the physician, and the amount of DNA in the samples taken and processed on day 1, and in those processed on day 14, using Ct thresholds. Descriptive statistics were applied. Overall concordance was estimated by means of the kappa coefficient and mean differences in DNA amount.

Results: A kappa coefficient of 0.84 (95% CI: 0.71-0.96) was found for concordance in high-risk HPV detection between the self-collected cervicovaginal sample and the sample taken by the clinician. There were no differences in terms of the amount of viral DNA between day 1  and day 14 (DM -0.34 cycles; 95% CI: - 2.29 to 1.61).

Conclusion: Self-collected vaginal samples using the storage device are reliable for high-risk HPV detection in patients with cervical dysplasia, and preserve viral DNA for 14 days if stored dry at room temperature. Confirmation studies in the general population are required.

Author Biographies

Luis Jairo Bonilla-Osma

Ginecólogo. Profesor del Diplomado de Colposcopia, Fundación
Universitaria Ciencias de la Salud - Hospital de San José, Bogotá (Colombia). ginejairo@yahoo.es

Jairo Amaya-Guio

Ginecólogo. Profesor Titular, Universidad Nacional de Colombia,
Subred Norte de servicios de Salud, Bogotá (Colombia).

Patricia Olaya-García

Bacterióloga; Microbióloga, Universidad Javeriana. Directora científica, Centro de Análisis Molecular, Bogotá (Colombia).

 

Luis Bonilla-Bula

Médico residente de Ginecología, FUCS - Hospital de San José, Bogotá (Colombia).

References

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. https://doi.org/10.1002/ijc.29210.

Profamilia, Colombia. Encuesta nacional de demografía y salud ENDS 2010 Colombia. Bogotá D.C.: Profamilia. 2010 [visitado 2018 sep 1]. Disponible en: http://profamilia.org.co/docs/ENDS %202010.pdf.

IARC Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France; 1995.

Ministerio de Salud y Protección Social, Instituto Nacional de Cancerología ESE. Guía de Práctica Clínica para la detección y manejo de lesiones precancerosas de cuello uterino. Colombia 2014 [visitado 2018 sep 1]. Disponible en: http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Otros_conv/GPC_cuello_uterino_inv/CCU_Guia_profesionales_julio_2016.pdf.

Castle PE, de Sanjosé S, Qiao Y-L, Belinson JL, Lazcano-Ponce E, Kinney W. Introduction of human papillomavirus DNA screening in the world: 15 years of experience. Vaccine. 2012;30:F117-22. https://doi.org/10.1016/j.vaccine.2012.05.071.

Gupta S, Palmer C, Bik EM, Cardenas JP, Nu-ez H, Kraal L, et al. Self-sampling for human papillomavirus testing: Increased cervical cancer screening participation and incorporation in international screening programs. Frontiers in Public Health. 2018;6:77. https://doi.org/10.3389/fpubh.2018.00077.

Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PPL, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database of Systematic Reviews 2017, Issue 8. CD008587. https://doi.org/10.1002/14651858.CD008587.pub2.

Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials. Lancet. 2014;383:524-32. https://doi.org/10.1016/S0140-6736(13)62218-7.

Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): A population-based cluster-randomised trial. Lancet Glob Health. 2015;3:e85-94. https://doi.org/ 10.1016/S2214-109X (14)70354-7.

Racey CS, Withrow DR, Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: A systematic review and meta-analysis. Can J Public Health. 2013;104:e159-66.

Gok M, Heideman DAM, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JWM, et al. HPV testing on self-collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: Cohort study. BMJ. 2010;340:c1040-c1040. https://doi.org/10.1136/bmj.c1040.

Catarino R, Vassilakos P, Stadali-Ullrich H, Royannez-Drevard I, Guillot C, Petignat P. Feasibility of at-home self-sampling for HPV testing as an appropriate screening strategy for nonparticipants in Switzerland. J Low Genit Tract Dis. 2015;19:27-34. https://doi.org/10.1097/LGT.0000000000000051

Mandigo M, Frett B, Laurent JR, Bishop I, Raymondville M, Marsh S, et al. Pairing community health workers with HPV self-sampling for cervical cancer prevention in rural Haiti. Int J Gynecol Obstet. 2015;128:206-10. https://doi.org/10.1016/j.ijgo.2014.09.016.

Curotto M, Barletta P, Paolino M, Arrossi S. La perspectiva de los agentes sanitarios sobre la incorporación programática de la autotoma del test de VPH. Cad Saúde Pública. 2017;33:1-13. https://doi.org/10.1590/0102-311x00138515.

Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The acceptability of self-sampled screening for HPV DNA: A systematic review and meta-analysis. Sex Transm Infect. 2017;93:56-61. https://doi.org/10.1136/sextrans-2016-052609.

Fairley CK, Chen S, Tabrizi SN, Quinn MA, McNeil JJ, Garland SM. Tampons: A novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis. 1992;165:1103-6. https://doi.org/10.1093/infdis/165.6.1103.

Brink AATP, Meijer CJLM, Wiegerinck MAHM, Nieboer TE, Kruitwagen RFPM, van Kemenade F, et al. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J Clin Microbiol. 2006;44:2518-23. https://doi.org/10.1128/JCM.02440-05.

Bais AG, van Kemenade FJ, Berkhof J, Verheijen RHM, Snijders PJF, Voorhorst F, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120:1505-10. https://doi.org/10.1002/ijc.22484.

Arbyn M, Verdoodt F, Snijders PJF, Verhoef VMJ, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: A meta-analysis. Lancet Oncol. 2014;15:172-83. https://doi.org/10.1016/S1470-2045(13)70570-9.

van Baars R, Bosgraaf RP, Harmsel BWA, Melchers WJG, Quint WGV, Bekkers RLM. Dry storage and transport of a cervicovaginal self-sample by use of the evalyn brush, providing reliable human papillomavirus detection combined with comfort for women. J Clin Microbiol. 2012;50:3937-43. DOI 10.1128/JCM.01506-12.

Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, et al. Self-collected samples for testing of oncogenic human papillomavirus: A systematic review. J Obstet Gynaecol Can. 2007;29:817-28. https://doi.org/10.1016/S1701-2163(16)32636-6.

Vassilakos P, Catarino R, Bougel S, Munoz M, Benski C, Meyer-Hamme U, et al. Use of swabs for dry collection of self-samples to detect human papillomavirus among Malagasy women. Infectious Agents and Cancer. 2016;11:13. https://doi.org/10.1186/s13027-016-0059-8.

Baay M, Verhoeven V, Lambrechts H, Pattyn G, Lardon F, Van Royen P, et al. Feasibility of collecting self-sampled vaginal swabs by mail: Quantity and quality of genomic DNA. Eur J Clin Microbiol Infect Dis. 2009;28:1285 -9. https://doi.org/10.1007/s10096-009-0776-7

How to Cite

1.
Bonilla-Osma LJ, Amaya-Guio J, Olaya-García P, Bonilla-Bula L. Evaluation of the usefulness of a device for Human Papilloma Virus DNA collection and reservation in self-collected cervicovaginal samples stored dry in women with cervical dysplasia, Bogotá, Colombia. Rev. colomb. obstet. ginecol. [Internet]. 2018 Sep. 28 [cited 2024 May 11];69(3):179-88. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/3149

Downloads

Download data is not yet available.

Published

2018-09-28

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo